Herpes simplex virus (HSV), a member of the Herpesviridae family, is a significant human
pathogen that results in mucocutaneous lesions in the oral cavity or genital infections …

Cytomegalovirus (CMV) infection is a significant complication in hematopoietic cell
transplantation (HCT) recipients. Four antiviral drugs are used for preventing or treating …

Despite advances in preventive strategies, cytomegalovirus (CMV) infection remains a major
complication in solid organ and hematopoietic cell transplant recipients. CMV infection may …

Background This drug resistance analysis of a randomized trial includes 234 patients
receiving maribavir and 116 receiving investigator-assigned standard therapy (IAT), where …

Antiviral therapy for cytomegalovirus (CMV) plays an important role in the clinical
management of solid organ and hematopoietic stem cell transplant recipients. However …

An increasing volume of information correlating CMV genotypes and drug susceptibility
phenotypes is becoming available. This will improve the interpretation of sequence-based …

Human cytomegalovirus (HCMV) is a significant pathogen in immunocompromised
individuals, with the potential to cause fatal pneumonitis and colitis, as well as increasing the …

Human cytomegalovirus (HCMV) infection is a major cause of morbidity and mortality in
allogeneic hematopoietic stem cell transplant recipients. The significant clinical impact of …

Human cytomegalovirus (HCMV) is a pathogen that can be life-threatening in
immunocompromised individuals. Valganciclovir and its parent drug ganciclovir are …

Many antiviral and anticancer drugs are nucleoside analogs that target polymerases and
cause DNA chain termination. Interestingly, ganciclovir (GCV), the first line of therapy for …